No Factors ID'd to Predict Re-Bleeding With Non-High-Risk Acute Variceal Bleeding

Follow Drugslib on

Medically reviewed by Judith Stewart, BPharm. Last updated on Dec 15, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 15, 2023 -- The majority of non-high-risk patients with acute variceal bleeding (AVB) have an excellent prognosis, but those who do re-bleed have higher risk of death, according to a study published online Oct. 16 in the Journal of Hepatology.

Lorenz Balcar, M.D., from the Medical University of Vienna, and colleagues examined prognostic factors for re-bleeding and mortality in non-high-risk AVB. Analysis included 2,225 adults with cirrhosis and variceal bleeding who were prospectively recruited from 34 centers (2011 to 2015).

The researchers found that 15 percent of patients re-bled and 12 percent died within one year of initial bleed. Based on routine clinical data, there were no meaningful predictors of re-bleeding. However, re-bleeding was associated with increased mortality, even after accounting for differences in patient characteristics (adjusted cause-specific hazard ratio: 2.57). Risk of death was stratified by a nomogram including Child-Turcotte-Pugh, creatinine, and sodium measured at baseline accurately (concordance: 0.752).

"Our study paves the way for future clinical trials evaluating whether elective transjugular intrahepatic portosystemic shunt placement improves outcomes in presumably 'non-high-risk' patients who are identified as being at increased risk of death," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-16 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords